List of works by Rossella Elisei

2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer

scientific article published on 19 December 2012

2019 European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer

scientific article published on 28 August 2019

A Comprehensive Meta-analysis of Case-Control Association Studies to Evaluate Polymorphisms Associated with the Risk of Differentiated Thyroid Carcinoma.

scientific article published on 3 February 2016

A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New RET Germline Deletion

scientific article published on 29 July 2020

A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer

scientific article published on 26 August 2015

A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer

scientific article published in May 2022

A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma

scientific article published on 12 February 2016

A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.

scientific article

A new germline RET mutation apparently devoid of transforming activity serendipitously discovered in a patient with atrophic autoimmune thyroiditis and primary ovarian failure.

scientific article published in October 2004

A patient with MEN1 and end-stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantation

scientific article published on 29 December 2017

A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment

scientific article published on 24 April 2015

Ablation of thyroid residues with 30 mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal

scientific article

Active Surveillance in Papillary Thyroid Microcarcinomas is Feasible and Safe: Experience at a Single Italian Center

scientific article published on 01 March 2020

Acute exogenous TSH administration stimulates leptin secretion in vivo

scientific article published on 14 April 2010

Advances in the follow-up of differentiated or medullary thyroid cancer

scientific article published on 03 April 2012

All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes.

scientific article

Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1.

scientific article

Analysis of circulating tumor DNA does not improve the clinical management of patients with locally advanced and metastatic papillary thyroid carcinoma.

scientific article published on 22 March 2018

Anaplastic thyroid cancer therapy: dream or reality?

scientific article published on 01 December 2012

Anaplastic thyroid cancer: prevalence, diagnosis and treatment.

scientific article

Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies

scientific article

Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question.

scientific article

Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer

scientific article published on April 2013

Association between BRAF V600E mutation and recurrence of papillary thyroid cancer.

scientific article

Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma

scientific article published on 19 January 2016

Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.

scientific article

BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid Cancer

scientific article published on 02 August 2018

BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment

scientific article published on 18 November 2017

BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer

scientific article published on 21 October 2021

BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma

scientific article published on 29 November 2019

BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas

scientific article

BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study

scientific article

BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer

scientific article published in June 2008

Biology and clinical application of the NIS gene.

scientific article published on September 2003

Breast Cancer After Treatment of Differentiated Thyroid Cancer With Radioiodine in Young Females: What We Know and How to Investigate Open Questions. Review of the Literature and Results of a Multi-Registry Survey

scientific article published on 10 July 2020

CDKN1B V109G polymorphism a new prognostic factor in sporadic medullary thyroid carcinoma.

scientific article

Ca19.9 positivity and doubling time are prognostic factors of mortality in patients with advanced medullary thyroid cancer with no evidence of structural disease progression according to RECIST

scientific article published on 24 November 2020

Cabozantinib (XL184) for the treatment of locally advanced or metastatic progressive medullary thyroid cancer.

scientific article

Cabozantinib in progressive medullary thyroid cancer

scientific article

Calcitonin estimation in patients with nodular goiter and its significance for early detection of MTC: european comments to the guidelines of the American Thyroid Association

scientific article published on 14 March 2013

Calcitonin receptor expression in medullary thyroid carcinoma

scientific article published on 13 September 2017

Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line.

scientific article published on 25 January 2012

Changing Trend of Thyroglobulin Antibodies in Patients With Differentiated Thyroid Cancer Treated With Total Thyroidectomy Without 131I Ablation

scientific article published on 01 July 2018

Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma

scientific article published on 16 August 2011

Circulating neuron-specific enolase in medullary thyroid cancer

scientific article published on 01 May 1986

Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland.

scientific article

Clinical and biologic behavior of bone metastases from differentiated thyroid carcinoma

scientific article published on 01 December 1989

Clinical case seminar in pediatric thyroid disease.

scientific article published on 29 August 2014

Clinical impact of molecular techniques for the presurgical diagnosis of differentiated thyroid cancer diagnosis

scientific article published on 24 April 2017

Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma

scientific article published on 11 April 2019

Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience.

scientific article

Clinically unpredictable prognostic factors in the outcome of medullary thyroid cancer

scientific article

Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hupsilonrthle cell thyroid lesions: results from a series of 505 consecutive patients

scientific article published on 01 January 2007

Conditional apoptosis induced by oncogenic ras in thyroid cells

scientific article

Congenital hypothyroidism due to a new deletion in the sodium/iodide symporter protein

scientific article published on 01 October 2003

Consenso europeo para el tratamiento de los pacientes con carcinoma tiroideo diferenciado del epitelio folicular

Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients

scientific article published on 01 September 2001

Correction: Inherited variants in genes somatically mutated in thyroid cancer

scientific article published in PLoS ONE

Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.

scientific article

Correlation between the BRAF V600E mutation and tumor invasiveness in papillary thyroid carcinomas smaller than 20 millimeters: analysis of 1060 cases.

scientific article published on 14 July 2010

Correlative Studies in Clinical Trials: A Position Statement From the International Thyroid Oncology Group

scientific article

Correlative analyses of RET and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer

scientific article

Cytotoxic effects of carboplatinum and epirubicin in the setting of an elevated serum thyrotropin for advanced poorly differentiated thyroid cancer

scientific article

DELAYED 131-I FIRST TREATMENT AFTER SURGERY HAS NO IMPACT ON THE MEDIAN TERM OUTCOME OF PATIENTS WITH INTERMEDIATE RISK DIFFERENTIATED THYROID CANCER

scientific article published on 26 September 2019

Definition and management of radioactive iodine-refractory differentiated thyroid cancer

scientific article published on 30 January 2014

Demonstration of the existence of the alternatively spliced form of thyroid peroxidase in normal thyroid

scientific article published on 01 March 1991

Detection of metastases from differentiated thyroid cancer by different imaging techniques (neck ultrasound, computed tomography and [18F]-FDG positron emission tomography) in patients with negative post-therapeutic ¹³¹I whole-body scan and detectab

scientific article published on 29 July 2014

Detection of thyroglobulin in fine needle aspirates of nonthyroidal neck masses: a clue to the diagnosis of metastatic differentiated thyroid cancer

scientific article published on 01 June 1992

Detection of thyroid-stimulating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptor.

scientific article published on February 1993

Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment

scientific article published on 01 April 2002

Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.

scientific article

Differential expression of RET isoforms in normal thyroid tissues, papillary and medullary thyroid carcinomas

scientific article published on 05 July 2019

Early treatment of hereditary medullary thyroid carcinoma after attribution of multiple endocrine neoplasia type 2 gene carrier status by screening for ret gene mutations

scientific article published on December 1995

Effect of an Outreach Programme on Vandetanib Safety in Medullary Thyroid Cancer.

scientific article published on 10 September 2016

Effects of radioiodine treatment for differentiated thyroid cancer on testis function

scientific article

Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA Trial

scientific article published on 25 June 2020

Elevated level of serum carbohydrate antigen 19.9 as predictor of mortality in patients with advanced medullary thyroid cancer

scientific article

Epidemiology of Simultaneous Medullary and Papillary Thyroid Carcinomas (MTC/PTC): An Italian Multicenter Study

scientific article published on 09 October 2019

Establishment of a non-tumorigenic papillary thyroid cell line (FB-2) carrying the RET/PTC1 rearrangement

scientific article published on February 2002

European Perspective on 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: Proceedings of an Interactive International Symposium.

scientific article

European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

scientific article

Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series.

scientific article published on 16 December 2012

Evidences that the polymorphism Pro-282-Ala within the tumor suppressor gene WWOX is a new risk factor for differentiated thyroid carcinoma

scientific article published on 25 April 2011

Exploratory analysis of biomarkers associated with clinical outcomes from the study of lenvatinib in differentiated cancer of the thyroid.

scientific article published on 23 February 2017

Expression analysis of facilitative glucose transporters (GLUTs) in human thyroid carcinoma cell lines and primary tumors

scientific article

Expression of cAMP response element-binding protein and sodium iodide symporter in benign non-functioning and malignant thyroid tumours

scientific article published in May 2003

Expression of calcitonin gene-related peptide in medullary thyroid cancer

scientific article published on 01 July 1992

Expression of p21 ras protein as a prognostic factor in papillary thyroid cancer

scientific article published on 01 January 1994

Expression of thyrotropin receptor (TSH-R), thyroglobulin, thyroperoxidase, and calcitonin messenger ribonucleic acids in thyroid carcinomas: evidence of TSH-R gene transcript in medullary histotype.

scientific article

Failure to use measurement of megalin secretory components complexed with serum thyroglobulin as a tool to identify metastases after surgery in papillary thyroid cancer

scientific article published on 01 July 2004

Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter study

scientific article published on 20 July 2019

Fifty Years After the First Description, MEN 2B Syndrome Diagnosis Is Still Late: Descriptions of Two Recent Cases

scientific article published on 01 July 2019

First report of benign track seeding after robot-assisted transaxillary thyroid surgery

scientific article published on 26 October 2020

Follicular-derived neoplasms: morphometric and genetic differences.

scientific article

Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal

scientific article published on 22 October 2009

FoxP3 expression in papillary thyroid carcinoma: a possible resistance biomarker to iodine 131 treatment

scientific article published on 26 September 2013

Galectin-3 and Oncofetal-Fibronectin Expression in Thyroid Neoplasia as Assessed by Reverse Transcription-Polymerase Chain Reaction and Immunochemistry in Cytologic and Pathologic Specimens

scientific article published on 01 August 2003

Galectin-3 is highly expressed in nonencapsulated papillary thyroid carcinoma but weakly expressed in encapsulated type; comparison with Hector Battifora mesothelial cell 1 immunoreactivity.

scientific article

Genetic Landscape of Somatic Mutations in a Large Cohort of Sporadic Medullary Thyroid Carcinomas Studied by Next-Generation Targeted Sequencing

scientific article published on 26 September 2019

Genetic and clinical features of multiple endocrine neoplasia types 1 and 2.

scientific article published on 8 November 2012

Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas

scientific article published on November 1998

Genome-wide association study on differentiated thyroid cancer

scientific journal article

Higher intratumoral expression of CD1a, tryptase, and CD68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: correlation with clinical and pathological parameters

scientific article published on 18 October 2011

How to manage patients with differentiated thyroid cancer and a rising serum thyroglobulin level.

scientific article published on June 2014

Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition

scientific article published on November 2004

Identification of rapid turnover transcripts overexpressed in thyroid tumors and thyroid cancer cell lines: use of a targeted differential RNA display method to select for mRNA subsets

scientific article

Identification of two distinct molecular subtypes by digital RNA counting of "non-invasive follicular tumour with papillary-like nuclear features (NIFTP)".

scientific article

Impact of Advanced Age on the Clinical Presentation and Outcome of Sporadic Medullary Thyroid Carcinoma

scientific article published on 30 December 2020

Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.

scientific article published on January 2004

Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement.

scientific article published on 03 August 2013

In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer.

scientific article published on 20 September 2011

Incidental occurrence of metastatic medullary thyroid carcinoma in a patient with multiple endocrine neoplasia type 1 carrying germline MEN1 and somatic RET mutations

scientific article published on 02 October 2017

Incidental versus clinically evident thyroid cancer: a 5-year follow-up study

scientific article published on 24 February 2012

Influence of human body composition on serum peak thyrotropin (TSH) after recombinant human TSH administration in patients with differentiated thyroid carcinoma

scientific article published on 03 May 2005

Inherited variants in genes somatically mutated in thyroid cancer

scientific article

Interventional bronchoscopy in the treatment of tracheal obstruction secondary to advanced thyroid cancer

scientific article

Involvement of protein kinase Cepsilon (PKCepsilon) in thyroid cell death. A truncated chimeric PKCepsilon cloned from a thyroid cancer cell line protects thyroid cells from apoptosis

scientific article

Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies

scientific article published on 04 May 2018

KIF5B/RET Rearrangement in a Carcinoma of the Thyroid Gland: A Case Report of a Fatal Disease

scientific article

Lack of evidence supporting the presence of mRNA for the thyrotropin receptor in extra-ocular muscle

scientific article published on May 1993

Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases.

scientific article published on 13 October 2004

Lenvatinib Administered via Nasogastric Tube in Poorly Differentiated Thyroid Cancer

scientific article published on 18 September 2019

Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer

scientific article

Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.

scientific article published in February 2015

Less than 2% of the Low- and Intermediate-Risk Differentiated Thyroid Cancers Show Distant Metastases at Post-Ablation Whole-Body Scan

scientific article published on 13 December 2018

Location of functioning metastases from differentiated thyroid carcinoma by simultaneous double isotope acquisition of I-131 whole body scan and bone scan

scientific article published in October 2004

Low prevalence of the somatic M918T RET mutation in micro-medullary thyroid cancer

scientific article

Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients.

scientific article published on January 2004

Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role

scientific article published on 15 June 2009

Lung Recurrence of Papillary Thyroid Cancer Diagnosed With Antithyroglobulin Antibodies After 10 Years From Initial Treatment

scientific article published on 09 October 2018

Lymphocyte and immature dendritic cell infiltrates in differentiated, poorly differentiated, and undifferentiated thyroid carcinoma

Management and follow-up of differentiated thyroid cancer not submitted to radioiodine treatment: a systematic review

scientific article published on 03 July 2020

Management of Medullary Thyroid Cancer

scientific article published on 26 December 2018

Markers of cell-proliferation as prognostic factors in differentiated thyroid-cancer

scientific article published on 01 December 1993

Measurement of cAMP accumulation in Chinese hamster ovary cells transfected with the recombinant human TSH receptor (CHO-R): a new bioassay for human thyrotropin.

scientific article

Medullary and papillary tumors are frequently associated in the same thyroid gland without evidence of reciprocal influence in their biologic behavior

article

Medullary thyroid cancer secreting carbohydrate antigen 19-9 (Ca 19-9): a fatal case report.

scientific article published on 16 July 2013

Medullary thyroid cancer treated with vandetanib: predictors of a longer and durable response

scientific article published on 20 January 2020

Medullary thyroid cancer. An immunohistochemical and humoral study using six separate antigens

scientific article published on 01 March 1991

Medullary thyroid carcinoma (MTC) and RET proto-oncogene: mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form

scientific article published on 08 October 2012

Medullary thyroid carcinoma in children.

scientific article published on 29 August 2014

Minimally invasive video-assisted thyroidectomy for papillary carcinoma: a prospective study of its completeness

scientific article published on December 2002

Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years

article

Molecular biology studies on mesothelioma tumor samples: preliminary data on H-ras, p21, and SV40.

scientific article published on January 1995

Molecular profiles of papillary thyroid tumors have been changing in the last decades: how could we explain it?

scientific article published on February 2014

Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes

scientific article published in June 2010

Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes

scholarly article by Cristina Romei et al published December 2010 in European Journal of Endocrinology

Muscle autoantigens in thyroid associated ophthalmopathy: the limits of molecular genetics

scientific article

N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation to thyroglobulin expression.

scientific article

Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study

scientific article published on 16 January 2019

New and old knowledge on differentiated thyroid cancer epidemiology and risk factors

scientific article published on January 2012

New breakpoints in both the H4 and RET genes create a variant of PTC-1 in a post-Chernobyl papillary thyroid carcinoma

scientific article published on July 2000

New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outcome of cases with double RET mutations.

scientific article published on 28 July 2016

No difference in the outcome of metastatic thyroid cancer patients when using recombinant or endogenous TSH

scientific article published on 01 July 2020

Non thyroidal second primary malignancies in differentiated thyroid cancer patients: is the incidence increased comparing to the general population and could it be a radioiodine therapy consequence?

scientific article published on 24 May 2020

Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk

scientific article

Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk

scientific article published on 16 July 2014

Obesity and the risk of papillary thyroid cancer: a pooled analysis of three case-control studies

scientific article

Obesity as a risk factor for thyroid cancer

scientific article published on 27 July 2020

Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up

scientific article published on 02 March 2020

Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patients.

scientific article

Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma.

scientific article published on 22 September 2017

Papillary Thyroid Carcinoma With Rare Exon 15 BRAF Mutation Has Indolent Behavior: A Single-Institution Experience.

scientific article published on 29 August 2016

Patient Age-Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid Cancer.

scientific article published on 14 December 2017

Patients with Indeterminate Thyroid Nodules at Cytology and Cancer at Histology Have a More Favorable Outcome Compared with Patients with Suspicious or Malignant Cytology

scientific article published on 01 October 2018

Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up

scientific article published on 26 April 2013

Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer.

scientific article

Polymorphisms within base and nucleotide excision repair pathways and risk of differentiated thyroid carcinoma.

scientific article published on 31 March 2016

Polymorphisms within the RET proto-oncogene and risk of sporadic medullary thyroid carcinoma

scientific article published on 31 March 2020

Post-surgical ablation of thyroid residues with radioiodine in Ukrainian children and adolescents affected by post-Chernobyl differentiated thyroid cancer

scientific article published on 01 June 2001

Post-surgical follow-up of differentiated thyroid cancer.

scientific article published on February 1995

Postoperative Thyroglobulin and Neck Ultrasound in the Risk Restratification and Decision to Perform 131I Ablation.

scientific article

Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma

scientific article

Potential Impact of BMI on the Aggressiveness of Presentation and Clinical Outcome of Differentiated Thyroid Cancer

scientific article published on 01 April 2020

Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma

scientific article

Presence of BRAF V600E in very early stages of papillary thyroid carcinoma

scientific article published on 01 May 2007

Pro64His (rs4644) polymorphism within galectin-3 is a risk factor of differentiated thyroid carcinoma and affects the transcriptome of thyrocytes engineered via CRISPR/Cas9 system

scientific article published on 14 December 2020

Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.

scientific article

Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study

scientific article published on 15 January 2015

Protein kinase inhibitors for the treatment of advanced and progressive radiorefractory thyroid tumors: From the clinical trials to the real life

scientific article

Proteinuria is a late-onset adverse event in patients treated with cabozantinib

scientific article published on 03 May 2020

RET Copy Number Alteration in Medullary Thyroid Cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic Frequency

scientific article published on 29 December 2020

RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population

scientific article published in July 2004

RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center

scientific article published on 25 September 2007

RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC).

scientific article published in February 2011

RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases.

scientific article published on 4 January 2018

RET protein expression has no prognostic impact on the long-term outcome of papillary thyroid carcinoma

scientific article published on 01 November 2001

RET proto-oncogene mutations in thyroid carcinomas: clinical relevance

scientific article

RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma.

scientific article

RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults

scientific article published on 01 July 2001

RET/PTC3 rearrangement and thyroid differentiation gene analysis in a struma ovarii fortuitously revealed by elevated serum thyroglobulin concentration.

scientific article published in December 2005

Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study.

scientific article published on 29 December 2005

Randomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinoma.

scientific article

Rare diseases in clinical endocrinology: a taxonomic classification system.

scientific article published on 7 November 2014

Re-differentiation of thyroid carcinoma cell lines treated with 5-Aza-2'-deoxycytidine and retinoic acid.

scientific article

Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy

scientific article published on 09 July 2019

Recombinant human TSH (rhTSH) in 2009: new perspectives in diagnosis and therapy.

scientific article published on October 2009

Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma

scientific article published on 01 August 2003

Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology

scientific article published on 12 August 2015

Regional approaches to the management of patients with advanced, radioactive iodine-refractory differentiated thyroid carcinoma

scientific article published on September 2012

Reply to the Letter to the Editor by Sollini M et al

scientific article published on 03 March 2016

Response to Letter to the Editor: Active Surveillance in Papillary Thyroid Microcarcinomas is Feasible and Safe: Experience at a Single Italian Center

scientific article published on 12 May 2020

Response to Letter: "Postoperative Thyroglobulin and Neck Ultrasound in the Risk Restratification and Decision to Perform 131I Ablation"

scientific article published on 01 May 2017

Retinoic acid receptor beta2 re-expression and growth inhibition in thyroid carcinoma cell lines after 5-aza-2'-deoxycytidine treatment.

scientific article published on August 2008

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma

scientific article

Risk of differentiated thyroid carcinoma and polymorphisms within the susceptibility cancer region 8q24.

scientific article published on 5 September 2013

Role of RET codonic mutations in the surgical management of medullary thyroid carcinoma in pediatric age multiple endocrine neoplasm type 2 syndromes.

scientific article published in August 2010

Role of YAP-1 in Thyroid Tumor Progression and Outcome.

scientific article

Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma

scientific article

Routine serum calcitonin measurement in the evaluation of thyroid nodules.

scientific article published on December 2008

Runs of homozygosity and inbreeding in thyroid cancer

scientific article

Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer

scientific article published on 01 February 2019

Safety and quality of life data from an Italian expanded access program of lenvatinib for treatment of thyroid cancer

scientific article published on 10 September 2020

Simian virus 40-like sequences from early and late regions in human thyroid tumors of different histotypes

scientific article published in February 2003

Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence

scientific article published on 01 April 1996

Somatostatin in medullary thyroid cancer. In vitro and in vivo studies.

scientific article

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

scientific article

Structural studies of the thyrotropin receptor and Gs alpha in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformation

scientific article

Studies with recombinant autoepitopes of thyroid peroxidase: evidence suggesting an epitope shared between the thyroid and the gastric parietal cell

scientific article published on January 1990

Successo terapeutico di Lenvatinib in seconda linea in un caso di carcinoma follicolare della tiroide avanzato

Surgical Management of Medullary Thyroid Carcinoma in Pediatric Age

scientific article published on 01 January 2016

Surgical treatment of low- and intermediate-risk papillary thyroid cancer with minimally invasive video-assisted thyroidectomy

scientific article published on 17 February 2009

Symptomatic and asymptomatic biliary disorders during lenvatinib treatment for advanced thyroid cancer is an underestimated problem

scientific article published on 29 July 2020

T cell responses to orbital antigens in thyroid-associated ophthalmopathy

scientific article published on May 1994

TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations.

scientific article published on 13 July 2013

Targeted Therapy in Thyroid Cancer: State of the Art.

scientific article published on 16 March 2017

The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study

scientific article published on 12 October 2012

The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy

scientific article published on 17 December 2019

The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer

scientific article published on 05 June 2017

The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway

scientific article published on 01 August 2000

The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma

scientific article

The polymorphism rs2480258 within CYP2E1 is associated with different rates of acrylamide metabolism in vivo in humans

scientific article published on 10 May 2018

The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center.

scientific article

Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels

scientific article published on 01 December 1987

Thyroglobulin autoantibodies as surrogate biomarkers in the management of patients with differentiated thyroid carcinoma.

scientific article published on January 2014

Thyroglobulin changes are highly dependent on TSH in low-risk DTC patients not treated with 131I

scientific article published on 26 May 2020

Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper

scientific article

Thyroid autoantibodies and thyroid function in subjects exposed to Chernobyl fallout during childhood: evidence for a transient radiation-induced elevation of serum thyroid antibodies without an increase in thyroid autoimmune disease.

scientific article published on 22 April 2008

Thyroid autoantibodies in thyroid cancer: incidence and relationship with tumour outcome

scientific article published on 01 November 1988

Thyroid cancer in children and adolescents

scientific article published on 01 December 1988

Thyroid carcinoma in thyrotoxic patients treated by surgery

scientific article published on 01 February 1988

Thyroid consequences of the Chernobyl nuclear accident

scientific article

Thyroid consequences of the Chernobyl nuclear accident

Thyroid nodule and differentiated thyroid cancer management in pregnancy. An Italian Association of Clinical Endocrinologists (AME) and Italian Thyroid Association (AIT) Joint Statement for Clinical Practice

scientific article published on 13 July 2010

Thyroid papillary carcinoma: preliminary evidence for a germ-line single nucleotide polymorphism in the Fas gene

article

Thyroidectomy followed by fosbretabulin (CA4P) combination regimen appears to suggest improvement in patient survival in anaplastic thyroid cancer

scientific article published on December 2012

Transfection with the cDNA of the human thyrotropin receptor of a poorly differentiated rat thyroid cell line (FRT).

scientific article

Treatment of advanced thyroid cancer with targeted therapies: ten years of experience

scientific article

Treatment with drugs able to reduce iodine efflux significantly increases the intracellular retention time in thyroid cancer cells stably transfected with sodium iodide symporter complementary deoxyribonucleic acid.

scientific article published on 14 March 2006

Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?

scientific article published on 29 December 2014

Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations

scientific article published on 10 September 2019

Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients

scientific article published on 30 August 2017

Using The Cancer Genome Atlas data to refine the 8th edition of the American Joint Committee on Cancer staging for papillary thyroid carcinoma

scientific article published on 11 September 2020

Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial

scientific article published on 24 October 2011

Video assisted prophylactic thyroidectomy and central compartment nodes clearance in two RET gene mutation adult carriers

scientific article

Video-assisted central compartment lymphadenectomy in a patient with a positive RET oncogene: initial experience

scientific article published on 06 September 2006

mRECIST criteria to assess recurrent thyroid carcinoma treatment response after radiofrequency ablation: a prospective study.

scientific article published on 23 April 2018

mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases

scientific article published on 24 September 2018

somatic mutations strongly impair miRNA processing even in benign thyroid lesions

scientific article published on 05 March 2019